Science Translational Medicine · 2022 · 41 citations · 24 references
MedicineChronic Disease ControlClinical EpidemiologyContinuity Of CareTemporal EpidemiologyBlood Pressure ControlDisease ControlHypertension ControlHypertension ManagementPatient AdherenceRetention In CareAdherence To Antihypertensive TherapyAging In Middle-income CountriesBlood PressureDrug DiscontinuationLongitudinal Care PathwaysPoisson ModelsPoisson RegressionTreatment Discontinuation Rates
Managing hypertension is a highly dynamic process, yet current evidence on hypertension control in middle-income countries (MICs) is largely based on cross-sectional data. Using multiple waves of population-based cohort data from four MICs (China, Indonesia, Mexico, and South Africa), we undertook a longitudinal investigation into how individuals with hypertension move through care over time. We classified adults aged 40 years and over ( N = 8527) into care stages at both baseline and follow-up waves and estimated the probability of transitioning between stages using Poisson regression models. Over a 5- to 9-year follow-up period, only around 30% of undiagnosed individuals became diagnosed [Mexico, 27% (95% confidence interval: 23%, 31%); China, 30% (26%, 33%); Indonesia, 30% (28%, 32%); and South Africa, 36% (31%, 41%)], and one in four untreated individuals became treated [Indonesia, 11% (10%, 12%); Mexico, 24% (20%, 28%); China, 26% (23%, 29%); and South Africa, 33% (29%, 38%)]. The probability of reaching blood pressure (BP) control was lower [Indonesia, 2% (1%, 2%); China, 9% (7%, 11%); Mexico, 12% (9%, 14%); and South Africa, 24% (20%, 28%)] regardless of treatment status. A substantial proportion of individuals discontinued treatment [Indonesia, 70% (67%, 73%); China, 36% (32%, 40%); Mexico, 34% (29%, 39%); and South Africa, 20% (15%, 25%)], and most individuals lost BP control by follow-up [Indonesia, 92% (89%, 96%); Mexico, 77% (71%, 83%); China, 76% (69%, 83%); and South Africa 45% (36%, 54%)]. Our results highlight that policies solely aimed at improving diagnosis or initiating treatment may not lead to long-term hypertension control improvements in MICs.
24
Bin Zhou, Rodrigo M. Carrillo‐Larco, Goodarz Danaei et al. · The Lancet · 2021 · 3.7K citations · Full text
Medicine, Chronic Disease Control, Clinical Epidemiology +16
Global Disparities of Hypertension Prevalence and Control
Katherine T. Mills, Joshua D. Bundy, Tanika N. Kelly et al. · Circulation · 2016 · 3.5K citations · Full text
James E. Bennett, Gretchen A Stevens, Colin Mathers et al. · The Lancet · 2018 · 1.4K citations · Full text
Social Sciences, Health Policy, Infectious Disease Control +16
Jiapeng Lu, Yuan Lu, Xiaochen Wang et al. · The Lancet · 2017 · 1.2K citations
Medicine, Population Health Sciences, Preventive Medicine +14